Login to Your Account

'It's Not on Their Radar'

COI Information Disappears from View in Meta-Analyses

By Anette Breindl

Wednesday, March 16, 2011
Researchers, regulatory agencies and the general public have become much more interested in funding transparency in recent years – for obvious reasons. Studies that are funded by a drug maker are, on the average, more sanguine about a given drug than those that are not.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription